Article Data

  • Views 2131
  • Dowloads 215

Original Research

Open Access

The severity of lower urinary tract symptoms is increased in patients with premature ejaculation among aging Korean men

  • Jae Hwi Choi1
  • Min Ho Lee1
  • Sin Woo Lee1
  • Chun Woo Lee1
  • Seong Uk Jeh1
  • See Min Choi1
  • Sung Chul Kam1
  • Jeong Seok Hwa1
  • Jae Seog Hyun1

1Department of Urology, Gyeongsang National University and Hospital, 52727 Jinju, Korea

DOI: 10.31083/jomh.2021.004 Vol.17,Issue 2,April 2021 pp.55-63

Published: 08 April 2021

*Corresponding Author(s): Jae Seog Hyun E-mail: hyunjs@gnu.ac.kr

Abstract

Introduction and objective: The purpose of this study was to compare the severity of lower urinary tract symptoms (LUTS) between patients with and without premature ejaculation (PE).

Materials and method: The relationship between the severity of LUTS and PE was investigated among 825 male subjects, who underwent medical check-up between July 2013 and July 2018 in our hospital. PE was defined by self-reported intravaginal ejaculation latency time (IELT). The severity of LUTS was determined by international prostate symptom score (IPSS), overactive bladder symptom score (OABSS), transrectal ultrasonography (TRUS), and uroflow rate. A total of 825 subjects were classified into three groups: PE-group (N = 60), Self-reported PE-group (N = 353), and Non-PE group (N = 412).

Results: In comparison analysis involving the two groups, the PE-group and the Self-reported PE-group were analyzed to be statistically significantly higher in IPSS items and OABSS items, compared to the Non-PE group (P < 0.05). This showed the same results in the univariate analysis (P < 0.05). Multivariate analysis conducted with the PE-group versus the Non-PE group, and the Self-reported PE-group versus the Non-PE group, revealed significant differences in the values of total IPSS (P < 0.05).

Conclusion: Comparison between the PE-group, which included the Self-reported PE-group, and the Non-PE group suggest that the severity of LUTS was comparatively higher in the PE-group. Thus, it is thought that being associated with or without PE may be a significant factor to consider, which affects LUTS severity.

Keywords

Lower urinary tract symptoms; Severity; Premature ejaculation

Cite and Share

Jae Hwi Choi,Min Ho Lee,Sin Woo Lee,Chun Woo Lee,Seong Uk Jeh,See Min Choi,Sung Chul Kam,Jeong Seok Hwa,Jae Seog Hyun. The severity of lower urinary tract symptoms is increased in patients with premature ejaculation among aging Korean men. Journal of Men's Health. 2021. 17(2);55-63.

References

[1] DeLay KJ, Nutt M, McVary KT. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms. Translational Andrology and Urology. 2016; 5: 450-459.

[2] Gray M, Zillioux J, Khourdaji I, Smith RP. Contemporary management of ejaculatory dysfunction. Translational Andrology and Urology. 2018; 7: 686-702.

[3] Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nature Reviews Neuroscience. 2008; 9: 453-466.

[4] Adegun PT, Areo PO, Solomon A, Dada SA, Adebayo PB. Erectile dysfunction in men with and without lower urinary tract symptoms in Nigeria. World Journal of Mens Health. 2017; 35: 107-114.

[5] Cho MC, Kim JK, Song SH, Cho SY, Lee SW, Kim SW, et al. Patient-reported ejaculatory function and satisfaction in men with lower urinary tract symptoms/benign prostatic hyperplasia. Asian Journal of Andrology. 2018; 20: 69-74.

[6] Silangcruz JM, Chua ME, Morales ML Jr. Prevalence and factor association of premature ejaculation among adult Asian males with lower urinary tract symptoms. Prostate International. 2015; 3: 65-69.

[7] Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States prevalence and predictors. Journal of the American Medical Association. 1999; 281: 537-544.

[8] Choi JH, Hwa JS, Kam SC, Jeh SU, Hyun JS. Effects of tamsulosin on premature ejaculation in men with benign prostatic hyperplasia. World Journal of Mens Health. 2014; 32: 99-104.

[9] Chen HR, Zhao FJ, Wang XH, Jiang Q, Zhang Q, Han BM, et al. The role of urethral pressure profile on treating premature ejaculation by tamsulosin. Asian Journal of Andrology. 2014; 16: 792-793.

[10] Chung E, Gilbert B, Perera M, Roberts MJ. Premature ejaculation: a clinical review for the general physician. Australian Family Physician. 2015; 44: 737-43.

[11] Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. Journal of Sexual Medicine. 2009; 6: 2888-2895.

[12] Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. Journal of Sexual Medicine. 2005; 2: 492-497.

[13] Kalejaiye O, Almekaty K, Blecher G, Minhas S. Premature ejaculation: challenging new and the old concepts. F1000Research. 2017; 6: 2084.

[14] Um JD, Kang DI, Yoon JH, Min KS. Correlation between lower urinary tract symptoms and premature ejaculation in Korean men older than 40 years old [corrected]. Korean Journal of Urology. 2012; 53: 189-193.

[15] Sihotang RC, Alvonico T, Taher A, Birowo P, Rasyid N, Atmoko W. Premature ejaculation in patients with lower urinary tract symptoms: a systematic review. International Journal of Impotence Research. 2020.

[16] Jeh SU, Yoon S, Choi JH, Do J, Seo DH, Lee SW, et al. Metabolic syndrome is an independent risk factor for acquired premature ejaculation. World Journal of Mens Health. 2019; 37: 226-233.

[17] Shin YS, Shin HS, Park JK. Lifestyle modification strategy for patients with premature ejaculation as metabolic syndrome. World Journal of Mens Health. 2019; 37: 372-373.

[18] Lee MH, Seo DH, Lee CW, Choi JH, Jeh SU, Lee SW, et al. Relationship between hypogonadal symptoms, sexual dysfunction and chronic prostatitis in middle-aged men by self-reported questionnaires, even without biochemical testosterone deficiency. World Journal of Mens Health. 2020; 38: 243-249.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.7 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top